Disease · MONDO_0007743
Comparisons in its trials163
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 163
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| All Ritalin LA vs Placebo: serious adverse events | 9 of 695 | 4 of 275 | 970 | NCT01259492 | Trial comparisons |
| Atomoxetine vs Placebo: serious adverse events | 4 of 266 | 3 of 234 | 500 | NCT00190775 | Trial comparisons |
| Atomoxetine vs Placebo: serious adverse events | 1 of 220 | 1 of 225 | 445 | NCT00510276 | Trial comparisons |
| Atomoxetine vs OEST: serious adverse events | 2 of 199 | 2 of 199 | 398 | NCT00447278 | Trial comparisons |
| Atomoxetine vs Placebo: serious adverse events | 1 of 193 | 2 of 195 | 388 | NCT00962104 | Trial comparisons |
| SPN-812 vs Placebo: deaths from any cause | 0 of 189 | 0 of 183 | 372 | NCT04016779 | Trial comparisons |
| SPN-812 vs Placebo: serious adverse events | 0 of 189 | 2 of 183 | 372 | NCT04016779 | Trial comparisons |
| OROS MPH vs PLACEBO: serious adverse events | 0 of 174 | 1 of 175 | 349 | NCT00937040 | Trial comparisons |
| Edivoxetine (Open-Label) vs Edivoxetine (Follow Up): serious adverse events | 7 of 264 | 1 of 80 | 344 | NCT00965419 | Trial comparisons |
| SPD503 vs PLACEBO: serious adverse events | 4 of 157 | 2 of 155 | 312 | NCT01081132 | Trial comparisons |
| Methylphenidate vs Methylphenidate (Placebo): serious adverse events | 4 of 151 | 7 of 152 | 303 | NCT00264797 | Trial comparisons |
| Very Light Breakfast (VLB) Then Standard Breakfast (SB) vs Standard Breakfast (SB) Then Very Light Breakfast (VLB): serious adverse events | 0 of 148 | 0 of 149 | 297 | NCT00428792 | Trial comparisons |
| Adhansia XR vs Concerta: deaths from any cause | 0 of 133 | 1 of 134 | 267 | NCT04507204 | Trial comparisons |
| Adhansia XR vs Concerta: serious adverse events | 3 of 133 | 4 of 134 | 267 | NCT04507204 | Trial comparisons |
| Lisdexamfetamine Dimesylate vs Atomoxetine Hydrochloride: serious adverse events | 0 of 128 | 0 of 134 | 262 | NCT01106430 | Trial comparisons |
| SPD489 vs Placebo: serious adverse events | 0 of 142 | 0 of 117 | 259 | NCT00697515 | Trial comparisons |
| Vyvanse vs Placebo: serious adverse events | 0 of 115 | 0 of 115 | 230 | NCT00500149 | Trial comparisons |
| Methylphenidate Transdermal System vs Placebo (PTS): serious adverse events | 1 of 145 | 1 of 72 | 217 | NCT00499863 | Trial comparisons |
| Methylphenidate Transdermal System vs Placebo (PTS): Improvement in Parent Global Assessment (PGA) Score | 76 of 143 | 15 of 72 | 215 | NCT00499863 | Trial comparisons |
| Methylphenidate Transdermal System vs Placebo (PTS): Improvement in Clinical Global Impressions-Improvement (CGI-I) Score | 93 of 143 | 22 of 72 | 215 | NCT00499863 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0007743/comparisons